Efficacy and Safety of Multi-Instillations of Apaziquone in Patients With Non-Muscle Invasive Bladder Cancer

NCT01410565 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

66

Enrollment

INDUSTRY

Sponsor class

Stopped Business reason

Conditions

Bladder Cancer

Interventions

DRUG: Apaziquone
DRUG: Placebo

Sponsor

Spectrum Pharmaceuticals, Inc

Collaborators

[object Object]